VEGF-A Promotes Both Pro-angiogenic and Neurotrophic Capacities for Nerve Recovery After Compressive Neuropathy in Rats

Griffin JW, Pan B, Polley MA, Hoffman PN, Farah MH (2010) Measuring nerve regeneration in the mouse. Exp Neurol 223(1):60–71. doi:10.1016/j.expneurol.2009.12.033 Ma CH, Omura T, Cobos EJ, Latremoliere A, Ghasemlou N, Brenner GJ, van Veen E, Barrett L, Sawada T, Gao F, Coppola G, Gertler F, Costigan M, Geschwind D, Woolf CJ (2011) Accelerating axonal growth promotes motor recovery after peripheral nerve injury in mice. J Clin Invest 121(11):4332–4347. doi:10.1172/JCI58675 Dahlin LB, Archer DR, McLean WG (1993) Axonal transport and morphological changes following nerve compression. An experimental study in the rabbit vagus nerve. J Hand Surg (Br) 18(1):106–110 Mackinnon SE, Dellon AL, Hudson AR, Hunter DA (1985) A primate model for chronic nerve compression. J Reconstr Microsurg 1(3):185–195. doi:10.1055/s-2007-1007073 Mackinnon SE, O'Brien JP, Dellon AL, McLean AR, Hudson AR, Hunter DA (1988) An assessment of the effects of internal neurolysis on a chronically compressed rat sciatic nerve. Plast Reconstr Surg 81(2):251–258 Pelletier J, Fromy B, Morel G, Roquelaure Y, Saumet JL, Sigaudo-Roussel D (2012) Chronic sciatic nerve injury impairs the local cutaneous neurovascular interaction in rats. Pain 153(1):149–157. doi:10.1016/j.pain.2011.10.001 Koeppen AH (2004) Wallerian degeneration: history and clinical significance. J Neurol Sci 220(1–2):115–117. doi:10.1016/j.jns.2004.03.008 Stoll G, Muller HW (1999) Nerve injury, axonal degeneration and neural regeneration: basic insights. Brain Pathol 9(2):313–325 Cui L, Jiang J, Wei L, Zhou X, Fraser JL, Snider BJ, Yu SP (2008) Transplantation of embryonic stem cells improves nerve repair and functional recovery after severe sciatic nerve axotomy in rats. Stem Cells 26(5):1356–1365. doi:10.1634/stemcells.2007-0333 Luis AL, Rodrigues JM, Geuna S, Amado S, Shirosaki Y, Lee JM, Fregnan F, Lopes MA, Veloso AP, Ferreira AJ, Santos JD, Armada-Da-silva PA, Varejao AS, Mauricio AC (2008) Use of PLGA 90:10 scaffolds enriched with in vitro-differentiated neural cells for repairing rat sciatic nerve defects. Tissue Eng Part A 14(6):979–993. doi:10.1089/ten.tea.2007.0273 Pereira Lopes FR, de Moura C, Campos L, Dias Correa J Jr, Balduino A, Lora S, Langone F, Borojevic R, Blanco Martinez AM (2006) Bone marrow stromal cells and resorbable collagen guidance tubes enhance sciatic nerve regeneration in mice. Exp Neurol 198(2):457–468. doi:10.1016/j.expneurol.2005.12.019 Shimizu S, Kitada M, Ishikawa H, Itokazu Y, Wakao S, Dezawa M (2007) Peripheral nerve regeneration by the in vitro differentiated-human bone marrow stromal cells with Schwann cell property. Biochem Biophys Res Commun 359(4):915–920. doi:10.1016/j.bbrc.2007.05.212 Johnson EO, Zoubos AB, Soucacos PN (2005) Regeneration and repair of peripheral nerves. Injury 36(Suppl 4):S24–S29. doi:10.1016/j.injury.2005.10.012 Pereira Lopes FR, Lisboa BC, Frattini F, Almeida FM, Tomaz MA, Matsumoto PK, Langone F, Lora S, Melo PA, Borojevic R, Han SW, Martinez AM (2011) Enhancement of sciatic-nerve regeneration after VEGF gene therapy. Neuropathol Appl Neurobiol. doi:10.1111/j.1365-2990.2011.01159.x Brockington A, Lewis C, Wharton S, Shaw PJ (2004) Vascular endothelial growth factor and the nervous system. Neuropathol Appl Neurobiol 30(5):427–446. doi:10.1111/j.1365-2990.2004.00600.x Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18(1):4–25 Sondell M, Lundborg G, Kanje M (1999) Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res 846(2):219–228 Sondell M, Lundborg G, Kanje M (1999) Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 19(14):5731–5740 Pawson EJ, Duran-Jimenez B, Surosky R, Brooke HE, Spratt SK, Tomlinson DR, Gardiner NJ (2010) Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes. Diabetes 59(2):509–518. doi:10.2337/db08-1526 Price SA, Dent C, Duran-Jimenez B, Liang Y, Zhang L, Rebar EJ, Case CC, Gregory PD, Martin TJ, Spratt SK, Tomlinson DR (2006) Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy. Diabetes 55(6):1847–1854. doi:10.2337/db05-1060 Carmeliet P, Tessier-Lavigne M (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436(7048):193–200. doi:10.1038/nature03875 Sondell M, Sundler F, Kanje M (2000) Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci 12(12):4243–4254 Storkebaum E, Lambrechts D, Carmeliet P (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26(9):943–954. doi:10.1002/bies.20092 Bruck W (1997) The role of macrophages in Wallerian degeneration. Brain Pathol 7(2):741–752 Zochodne DW (2000) The microenvironment of injured and regenerating peripheral nerves. Muscle Nerve Suppl 9:S33–S38. doi:10.1002/1097-4598(2000)999:9<::AID-MUS7>3.0.CO;2-F Reichert F, Levitzky R, Rotshenker S (1996) Interleukin 6 in intact and injured mouse peripheral nerves. Eur J Neurosci 8(3):530–535 Di Giovanni S, Knights CD, Rao M, Yakovlev A, Beers J, Catania J, Avantaggiati ML, Faden AI (2006) The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO J 25(17):4084–4096. doi:10.1038/sj.emboj.7601292 Tedeschi A, Nguyen T, Puttagunta R, Gaub P, Di Giovanni S (2009) A p53-CBP/p300 transcription module is required for GAP-43 expression, axon outgrowth, and regeneration. Cell Death Differ 16(4):543–554. doi:10.1038/cdd.2008.175 Dey A, Tergaonkar V, Lane DP (2008) Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways. Nat Rev Drug Discov 7(12):1031–1040. doi:10.1038/nrd2759 Gupta R, Rowshan K, Chao T, Mozaffar T, Steward O (2004) Chronic nerve compression induces local demyelination and remyelination in a rat model of carpal tunnel syndrome. Exp Neurol 187(2):500–508. doi:10.1016/j.expneurol.2004.02.009 Gupta R, Steward O (2003) Chronic nerve compression induces concurrent apoptosis and proliferation of Schwann cells. J Comp Neurol 461(2):174–186. doi:10.1002/cne.10692 Chao T, Pham K, Steward O, Gupta R (2008) Chronic nerve compression injury induces a phenotypic switch of neurons within the dorsal root ganglia. J Comp Neurol 506(2):180–193. doi:10.1002/cne.21537 Ruscheweyh R, Forsthuber L, Schoffnegger D, Sandkuhler J (2007) Modification of classical neurochemical markers in identified primary afferent neurons with Abeta-, Adelta-, and C-fibers after chronic constriction injury in mice. J Comp Neurol 502(2):325–336. doi:10.1002/cne.21311 Chandrasekaran L, He CZ, Al-Barazi H, Krutzsch HC, Iruela-Arispe ML, Roberts DD (2000) Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1. Mol Biol Cell 11(9):2885–2900 Webber C, Zochodne D (2009) The nerve regenerative microenvironment: early behavior and partnership of axons and Schwann cells. Exp Neurol 223(1):51–59. doi:10.1016/j.expneurol.2009.05.037 Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA (1996) Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 271(1):21–24 Isenberg JS, Annis DS, Pendrak ML, Ptaszynska M, Frazier WA, Mosher DF, Roberts DD (2009) Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses. J Biol Chem 284(2):1116–1125. doi:10.1074/jbc.M804860200 Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD (2009) Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer 9(3):182–194. doi:10.1038/nrc2561 Isenberg JS, Yu C, Roberts DD (2008) Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells. Biochem Pharmacol 75(4):875–882. doi:10.1016/j.bcp.2007.10.025 Elzie CA, Murphy-Ullrich JE (2004) The N-terminus of thrombospondin: the domain stands apart. Int J Biochem Cell Biol 36(6):1090–1101. doi:10.1016/j.biocel.2003.12.012 Liu A, Mosher DF, Murphy-Ullrich JE, Goldblum SE (2009) The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia. Microvasc Res 77(1):13–20. doi:10.1016/j.mvr.2008.08.008 Roudier E, Gineste C, Wazna A, Dehghan K, Desplanches D, Birot O (2010) Angio-adaptation in unloaded skeletal muscle: new insights into an early and muscle type-specific dynamic process. J Physiol 588(Pt 22):4579–4591. doi:10.1113/jphysiol.2010.193243 Lambrechts D, Carmeliet P (2006) VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochim Biophys Acta 1762(11–12):1109–1121. doi:10.1016/j.bbadis.2006.04.005 Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10(11):1361–1368. doi:10.1038/nn1992 Hobson MI, Green CJ, Terenghi G (2000) VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J Anat 197(Pt 4):591–605 Hoke A (2006) Neuroprotection in the peripheral nervous system: rationale for more effective therapies. Arch Neurol 63(12):1681–1685. doi:10.1001/archneur.63.12.1681 Marchand F, Perretti M, McMahon SB (2005) Role of the immune system in chronic pain. Nat Rev Neurosci 6(7):521–532. doi:10.1038/nrn1700 Shamash S, Reichert F, Rotshenker S (2002) The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci 22(8):3052–3060 Wang L, Lee HK, Seo IA, Shin YK, Lee KY, Park HT (2009) Cell type-specific STAT3 activation by gp130-related cytokines in the peripheral nerves. Neuroreport 20(7):663–668. doi:10.1097/WNR.0b013e32832a09f8 Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA (2001) Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol 169(2):386–391. doi:10.1006/exnr.2001.7677 Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994) Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165(1–2):208–210 Lee SJ, Drabik K, Van Wagoner NJ, Lee S, Choi C, Dong Y, Benveniste EN (2000) ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J Immunol 165(8):4658–4666 Pham CT (2006) Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 6(7):541–550. doi:10.1038/nri1841 Khurana VG, Meyer FB (2003) Translational paradigms in cerebrovascular gene transfer. J Cereb Blood Flow Metab 23(11):1251–1262. doi:10.1097/01.WCB.0000093324.07718.D4 Moens AL, Goovaerts I, Claeys MJ, Vrints CJ (2005) Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 127(6):2254–2263. doi:10.1378/chest.127.6.2254 Iida H, Schmeichel AM, Wang Y, Schmelzer JD, Low PA (2007) Orchestration of the inflammatory response in ischemia–reperfusion injury. J Peripher Nerv Syst 12(2):131–138. doi:10.1111/j.1529-8027.2007.00132.x Dudeck A, Leist M, Rubant S, Zimmermann A, Dudeck J, Boehncke WH, Maurer M (2010) Immature mast cells exhibit rolling and adhesion to endothelial cells and subsequent diapedesis triggered by E- and P-selectin, VCAM-1 and PECAM-1. Exp Dermatol 19(5):424–434. doi:10.1111/j.1600-0625.2010.01073.x Wee H, Oh HM, Jo JH, Jun CD (2009) ICAM-1/LFA-1 interaction contributes to the induction of endothelial cell–cell separation: implication for enhanced leukocyte diapedesis. Exp Mol Med 41(5):341–348. doi:10.3858/emm.2009.41.5.038 Chikuma T, Yoshimoto T, Ohba M, Sawada M, Kato T, Sakamoto T, Hiyama Y, Hojo H (2009) Interleukin-6 induces prostaglandin E(2) synthesis in mouse astrocytes. J Mol Neurosci 39(1–2):175–184. doi:10.1007/s12031-009-9187-6 Hinson RM, Williams JA, Shacter E (1996) Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci U S A 93(10):4885–4890 Leung L, Cahill CM (2010) TNF-alpha and neuropathic pain—a review. J Neuroinflammation 7:27. doi:10.1186/1742-2094-7-27 Lee KM, Jeon SM, Cho HJ (2009) Tumor necrosis factor receptor 1 induces interleukin-6 upregulation through NF-kappaB in a rat neuropathic pain model. Eur J Pain 13(8):794–806. doi:10.1016/j.ejpain.2008.09.009 Armstrong SJ, Wiberg M, Terenghi G, Kingham PJ (2008) Laminin activates NF-kappaB in Schwann cells to enhance neurite outgrowth. Neurosci Lett 439(1):42–46. doi:10.1016/j.neulet.2008.04.091 Brambilla R, Hurtado A, Persaud T, Esham K, Pearse DD, Oudega M, Bethea JR (2009) Transgenic inhibition of astroglial NF-kappa B leads to increased axonal sparing and sprouting following spinal cord injury. J Neurochem 110(2):765–778. doi:10.1111/j.1471-4159.2009.06190.x Smith D, Tweed C, Fernyhough P, Glazner GW (2009) Nuclear factor-kappaB activation in axons and Schwann cells in experimental sciatic nerve injury and its role in modulating axon regeneration: studies with etanercept. J Neuropathol Exp Neurol 68(6):691–700. doi:10.1097/NEN.0b013e3181a7c14e Miyazawa K, Mori A, Yamamoto K, Okudaira H (1998) Transcriptional roles of CCAAT/enhancer binding protein-beta, nuclear factor-kappaB, and C-promoter binding factor 1 in interleukin (IL)-1beta-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes. J Biol Chem 273(13):7620–7627 Persson E, Voznesensky OS, Huang YF, Lerner UH (2005) Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-kappaB, in mouse calvarial osteoblasts. Bone 37(4):513–529. doi:10.1016/j.bone.2005.04.043 Tuyt LM, Dokter WH, Birkenkamp K, Koopmans SB, Lummen C, Kruijer W, Vellenga E (1999) Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. J Immunol 162(8):4893–4902 Xiao W, Hodge DR, Wang L, Yang X, Zhang X, Farrar WL (2004) Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells. Prostate 61(4):354–370. doi:10.1002/pros.20113 Arruda JL, Sweitzer S, Rutkowski MD, DeLeo JA (2000) Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res 879(1–2):216–225 Barnes PJ, Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336(15):1066–1071. doi:10.1056/NEJM199704103361506 Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, Tracey K, Martin D, Maier SF, Watkins LR (2003) Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23(3):1026–1040 Sweitzer S, Martin D, DeLeo JA (2001) Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103(2):529–539 Verma S, Buchanan MR, Anderson TJ (2003) Endothelial function testing as a biomarker of vascular disease. Circulation 108(17):2054–2059 Gaub P, Joshi Y, Wuttke A, Naumann U, Schnichels S, Heiduschka P, Di Giovanni S (2011) The histone acetyltransferase p300 promotes intrinsic axonal regeneration. Brain 134(Pt 7):2134–2148. doi:10.1093/brain/awr142 Gaub P, Tedeschi A, Puttagunta R, Nguyen T, Schmandke A, Di Giovanni S (2010) HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death Differ 17(9):1392–1408. doi:10.1038/cdd.2009.216 Moore DL, Goldberg JL (2011) Multiple transcription factor families regulate axon growth and regeneration. Dev Neurobiol. doi:10.1002/dneu.20934 Tedeschi A, Di Giovanni S (2009) The non-apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon. EMBO Rep 10(6):576–583. doi:10.1038/embor.2009.89 Carter S, Bischof O, Dejean A, Vousden KH (2007) C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol 9(4):428–435. doi:10.1038/ncb1562 Choy MK, Movassagh M, Bennett MR, Foo RS (2009) PKB/Akt activation inhibits p53-mediated HIF1A degradation that is independent of MDM2. J Cell Physiol 222(3):635–639. doi:10.1002/jcp.21980 Hashimoto T, Ichiki T, Ikeda J, Narabayashi E, Matsuura H, Miyazaki R, Inanaga K, Takeda K, Sunagawa K (2011) Inhibition of MDM2 attenuates neointimal hyperplasia via suppression of vascular proliferation and inflammation. Cardiovasc Res 91(4):711–719. doi:10.1093/cvr/cvr108 Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8(1):49–62. doi:10.1038/nrm2083 el-Deiry WS (1998) Regulation of p53 downstream genes. Semin Cancer Biol 8(5):345–357